TEST, RIA, SERUM DIGOXIN— 510(k) K760077

Substantially Equivalent

Smithkline Diagnostics, Inc.

FDA 510(k) clearance K760077 for TEST, RIA, SERUM DIGOXIN, Substantially Equivalent on 1976-07-16. Applicant: Smithkline Diagnostics, Inc..

Clearance details

Applicant: Smithkline Diagnostics, Inc.
Product code: Code DND
Advisory panel: Clinical Toxicology
Date received: 1976-06-18
Decision date: 1976-07-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.